Kenneth B. Gordon, MD; Richard G. Langley, MD; Richard B. Warren, MD, PhD; et al.
open access
JAMA Dermatol. 2022;158(7):735-744. doi:10.1001/jamadermatol.2022.1185
This cohort study assesses the longer-term safety profile of bimekizumab in patients with moderate to severe plaque psoriasis from pooled results of 2 randomized clinical trials.
Zhijie Ruan, MMed; Tao Lu, MD; Yanxia Chen, MMed; et al.
free access
JAMA Dermatol. 2022;158(7):745-753. doi:10.1001/jamadermatol.2022.1609
This cross-sectional study uses data from the National Health and Nutrition Examination Survey to examine the association between psoriasis and nonalcoholic fatty liver disease among outpatient US adults.
Giovanni Pellacani, MD; Francesca Farnetani, MD; Silvana Ciardo, BS; et al.
open access
JAMA Dermatol. 2022;158(7):754-761. doi:10.1001/jamadermatol.2022.1570
This randomized clinical trial tests the hypothesis that reflectance confocal microscopy reduces unnecessary lesion excision by more than 30% and identifies all melanoma lesions larger than 0.5 mm at baseline.
Christian Enevold, PhD; Nikolai Loft, MD; Anne Bregnhøj, PhD; et al.
free access
JAMA Dermatol. 2022;158(7):762-769. doi:10.1001/jamadermatol.2022.1863
This case series study assesses measured trough levels of circulating brodalumab in patients with psoriasis who experienced treatment failure with anti鈥搃nterleukin 17A and whether brodalumab levels were associated with clinical response.
Amanda Maisel-Campbell, MD; Katherine A. Lin, BS; Sarah A. Ibrahim, BA; et al.
free access
JAMA Dermatol. 2022;158(7):770-778. doi:10.1001/jamadermatol.2022.1733
This cohort study examines the characteristics considered by physicians for Mohs surgery among patients older than age 85 years with nonmelanoma skin cancer.
Hanxi Zhao, MD, PhD; Wanqi Zhu, MD; Xianguang Zhao, MD; et al.
free access
JAMA Dermatol. 2022;158(7):779-786. doi:10.1001/jamadermatol.2022.1736
This randomized clinical trial assesses if epigallocatechin-3-gallate solution reduces the incidence of radiation-induced dermatitis in patients undergoing radiotherapy after breast cancer surgery.